tiprankstipranks
Trending News
More News >
Traws Pharma (TRAW)
NASDAQ:TRAW
US Market

Traws Pharma (TRAW) Income Statement

Compare
1,858 Followers

Traws Pharma Income Statement

Last quarter (Q2 2025), Traws Pharma's total revenue was $2.73M, an increase of 2318.58% from the same quarter last year. In Q2, Traws Pharma's net income was $-625.00K. See Traws Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 226.00K$ 226.00K$ 226.00K$ 226.00K$ 231.00K
Gross Profit
$ 214.00K$ 226.00K$ 226.00K$ 226.00K$ 231.00K
Operating Expenses
$ 49.56M$ 20.52M$ 19.85M$ 16.72M$ 25.22M
Depreciation and Amortization
$ 12.00K$ 16.00K$ 14.00K$ 14.00K$ 13.00K
EBITDA
$ -166.51M$ -20.28M$ -19.61M$ -16.48M$ -24.98M
Operating Income
$ -49.35M$ -20.30M$ -19.63M$ -16.50M$ -24.99M
Other Income/Expenses
$ -117.17M$ 1.35M$ 663.00K$ 333.00K$ -160.00K
Pretax Income
$ -166.52M$ -18.95M$ -18.96M$ -16.16M$ -25.15M
Net Income
$ -54.67M$ -18.95M$ -18.96M$ -16.16M$ -25.16M
Per Share Metrics
Basic EPS
$ -35.21$ -22.57$ -22.68$ -24.01$ -54.21
Diluted EPS
$ -35.21$ -22.57$ -22.68$ -24.01$ -54.21
Weighted Average Shares Outstanding
1.55M 839.55K 836.33K 673.29K 464.10K
Weighted Average Shares Outstanding (Diluted)
1.55M 839.55K 836.33K 673.29K 464.10K
Currency in USD

Traws Pharma Earnings and Revenue History